- Home
- NCL vs ACON Comparison
NCL vs ACON Comparison
Compare NCL & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCL | ACON |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | NCL | ACON |
|---|---|---|
| Price | $0.15 | $3.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 173.7K | 71.2K |
| Earning Date | 11-14-2025 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,349,854.00 | N/A |
| Revenue This Year | N/A | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.86 | N/A |
| 52 Week Low | $0.10 | $2.34 |
| 52 Week High | $1.47 | $15.08 |
Technical Indicators
Market Signals| Indicator | NCL | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 40.72 | 53.11 |
| Support Level | $0.14 | $2.38 |
| Resistance Level | $0.17 | $3.52 |
| Average True Range (ATR) | 0.02 | 0.21 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 64.71 | 48.67 |
Price Performance
Historical ComparisonAbout NCL Northann Corp.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. It offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, mainly through its sales network in North America and Europe.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.